Jim Cramer's Mad Dash: V MA EW

NEW YORK (TheStreet) -- People are worrying about Visa (V) and MasterCard (MA), TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said on CNBC's "Cramer's Mad Dash" segment Monday. But he can't understand why because the credit card companies' stocks appear to have stabilized. 

He pointed out that R.W. Baird upgraded both stocks to buy from neutral, giving Visa a price target of $245 and MasterCard a price target of $83. 

Cramer likes Visa at current levels because it has sold off too much. MasterCard missed its recent earnings report but he called the stock "cheap" at current levels. 

Turning to Edward Lifesciences (EW), he praised the company's new device that allows surgeons to perform open-heart surgery without opening the chest cavity. 

The U.S. District Court in Delaware granted a preliminary injunction in favor of Edward Lifesciences as well, Cramer said. The ruling limits the sale of the CoreValve system, Medtronic's (MDT) device for open-heart surgery. 

Cramer said the ruling is very bullish for Edward Lifesciences and thinks the stock can now reach $100.

-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

2 More Reasons to Sell All Your Stocks and Run Away

2 More Reasons to Sell All Your Stocks and Run Away

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast